Athens Research/Cambio - Excellence in Molecular Biology/10 AEU (100ug)/ATW0055-100

价格
面议
货号:ATW0055-100
浏览量:106
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Aptamers

Aptamers: Catalogue Aptamers

Please remember to pick your Modification from "Related items"

If the listed modifications do not meet your needs many other modifications are available on request

All Aptamers from Base Pair Bio are available with the following modifications

Please choose your modification and add as an extra catalogue number:

ATWUNMOD - Unmodified

ATWAMINE - Amine modification

ATWBIOTIN - Biotin modification

ATWTHIOL - Thiol modification (extra charge)

ATWFLUOR - Fluor (all) modification (extra charge)

  • Catalogue
  • Description
  • Notes

CA125/MUC16 (hu)

Recombinant Human CA125/MUC16

Base Pair Bio

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
ATW0055-100CA125/MUC16 (hu)10 AEU (100ug)POAQuantityAdd to Order
ATW0055-25CA125/MUC16 (hu)2.5 AEU (25ug)POAQuantityAdd to Order

CA125/MUC16 (hu)

Recombinant Human CA125/MUC16

Base Pair Bio

Cancer antigen 125 is a glycoprotein expressed in coelomic epithelial tissues, including the ovaries, kidney, and stomach. Elevated CA 125 levels are linked to many types of cancer and other conditions. CA-125 is elevated in ~80% of cases involving advanced epithelial ovarian cancer. CA 125 measurement is currently used for diagnostic and prognostic testing.

Aptamer was selected at Base Pair from a randomized 32-mer DNA library against the target protein protein. Proprietary methods were then used to select the aptamer.

Target: CA-125 (cancer antigen 125)

Target Species: human

Target Type: protein

Affinity Constant (Kd): 18.4 nM

Default 3" Linker (Spacer) is 10T. Please submit a custom quote request for other options.

DataSheet

0.1uM synthesis scale (20-200ug)Please choose your modification and add as an extra catalogue number:ATWUNMOD - UnmodifiedATWAMINE - Amine modificationATWBIOTIN - Biotin modificationATWTHIOL - Thiol modification (extra charge)ATWFLUOR - Fluor (all) modification (extra charge)

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

CA125/MUC16 (hu)

Recombinant Human CA125/MUC16

Base Pair Bio

Please note that aptamers have much lower molecular weights than antibodies. Thus, there are typically five to fifteen times as many moles or molecules of aptamers present in a solution containing an equal mass. For example, 100 micrograms of an aptamer is equivalent to 0.5 to 1.5 mg of antibody, depending on the particular aptamer.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.